ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

The Impact of Antibiotic Therapy on Clinical Outcomes in Kidney Transplant Recipients with Asymptomatic Bacteriuria

J. Gabriel1, S. Shaikh2, J. Park1, S. Tischer1, D. Kaul1, T. Patel1

1Michigan Medicine, Ann Arbor, MI, 2MedStar Georgetown University Hospital, Washington, DC

Meeting: 2019 American Transplant Congress

Abstract number: 464

Keywords: Infection, Reinfection, Risk factors, Urinalysis

Session Information

Session Name: Concurrent Session: Novel Insights in Kidney Infections

Session Type: Concurrent Session

Date: Tuesday, June 4, 2019

Session Time: 2:30pm-4:00pm

 Presentation Time: 3:30pm-3:42pm

Location: Room 311

*Purpose: Asymptomatic bacteriuria (ASB) occurs in nearly 50% of kidney transplant recipients (KTRs) in the first year post-transplant. Data evaluating the risk of untreated ASB on progression to symptomatic urinary tract infection (UTI) and allograft outcomes remains limited. Thus, antibiotics are often prescribed in this population. The purpose of this study was to evaluate the impact of antibiotic treatment for ASB on outcomes in KTRs.

*Methods: In this single-center, retrospective cohort study of adult KTRs between January 2009 and August 2015, patients who received antibiotics for the treatment of ASB were compared to those with untreated ASB. Patients with urostomies, indwelling catheters, nephrourteral stents, perinephric abscesses, urosepsis, and those requiring intermittent catheterization were excluded. The primary outcome was a composite of symptomatic cystitis and pyelonephritis. Secondary endpoints included allograft-related outcomes.

*Results: Of 150 included KTRs with ASB, 57% were prescribed antibiotics. The median age of the entire cohort was 55 and majority were females (62.7%). Other baseline characteristics were similar between the two groups except more patients in the treated group had a living unrelated kidney transplant (26.6% vs. 12.8%, p=0.04), and more patients in the untreated group had glomerulonephritis as their indication for transplant (10.5% vs 1.6%, p=0.04). ASB commonly occurred within the first month post-transplant (median time to index ASB case, 23 days). Antibiotic treatment was more common in KTRs with urine cultures having CFU > 105 (80.2% vs. 45.3%, p <0.01). No difference in the primary composite outcome was observed among KTRs treated with antibiotics for ASB versus those left untreated (14% vs. 18.8%, p=0.50). Additionally, no significant differences in secondary outcomes were seen (Table 1). Among KTRs with ASB who were treated with antibiotics, a median of 7 days was prescribed and de-escalation to a narrower spectrum agent was possible in 45.3% of patients.

*Conclusions: KTRs with untreated ASB have similar outcomes as those prescribed antibiotics, even in the early post-transplant period. Our findings suggest a role for antimicrobial stewardship by discouraging antibiotic use in this population.

Table 1. Outcomes
Outcome Treated (N=64) Untreated (N=86) p-value
Pyelonephritis 6 (9.4%) 5 (5.8%) 0.53
Cystitis 6 (9.4%) 7 (8.1%) 0.78
Graft loss (1 year post-transplant) 4 (6.3%) 6 (7.0%) >0.99
Graft rejection (1 year post-transplant) 14 (21.9%) 17 (19.8%) 0.84
30 day all-cause mortality 0 1 (1.2%) >0.99
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

To cite this abstract in AMA style:

Gabriel J, Shaikh S, Park J, Tischer S, Kaul D, Patel T. The Impact of Antibiotic Therapy on Clinical Outcomes in Kidney Transplant Recipients with Asymptomatic Bacteriuria [abstract]. Am J Transplant. 2019; 19 (suppl 3). https://atcmeetingabstracts.com/abstract/the-impact-of-antibiotic-therapy-on-clinical-outcomes-in-kidney-transplant-recipients-with-asymptomatic-bacteriuria/. Accessed May 31, 2025.

« Back to 2019 American Transplant Congress

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences